Canada’s Public Health Agency Orders Provinces to Destroy Old COVID Shots
Officials at the Public Health Agency of Canada (PHAC), the federal regulatory agency that manages public health affairs in Canada, told provincial governments to destroy existing COVID-19 shots to avoid confusion with new formulations of the booster shot that has the same drug identification number.1 COVID Shots That Target Older SARS-CoV-2 Variants to Be Destroyed […]
Pfizer/BioNTech mRNA Combo Influenza and COVID Shot Efficacy Fails in Trial
Pfizer and BioNTech recently announced that a new mRNA vaccine designed to protect against both COVID-19 and influenza in a single shot faced a major setback after failing to achieve one of its primary goals in a late-stage trial. The “primary goal” missed in the late-stage trials was the ability to effectively prevent influenza B. […]
Risk of Infection Increases With Each mRNA COVID-19 Vaccine Dose, Study Shows
New research raises serious questions about the COVID-19 vaccine’s long-term effectiveness and potential role in increasing susceptibility to infection. In a recent peer-reviewed study published in Clinical Infectious Diseases, researchers found that the risk of COVID-19 increased as the number of vaccine doses increased and the vaccine became increasingly less effective against variants different from those […]
CDC Narrows RSV Vaccine Guidelines Due to Safety Concerns
The U.S. Centers for Disease Control and Prevention (CDC) has recently narrowed its original recommendations for the respiratory syncytial virus (RSV) vaccine, citing concerns over the risk of a side effect that can lead to paralysis or death. The recommendations originally stated adults over the age of 60 should receive the vaccine, but updates in […]
Reports of Eye Disorders Spike After COVID Shots
In 2021, the World Health Organization’s (WHO) European drug monitoring system known as Vigibase, maintained by the Uppsala Monitoring Centre (UMC) in Sweden, received 19,916 reports of eye disorders following administration of COVID-19 shots. Vigibase had never recorded such a big spike in eye disorders until these biologics were introduced into the European market.1 Eye […]
Novel Breast Cancer Vaccine Technology Receives Japanese Patent
Anixa Biosciences, Inc. of San Jose, California announced on July 17, 2024, that its collaborator, the Cleveland Clinic, has received a “Decision to Grant” notice from the Japan Patent Office (JPO) for the patent application titled “Vaccine Adjuvants and Formulations” for its novel breast cancer vaccine technology. The company is two decades into developing a […]